INFU
InfuSystem Holdings Inc

604
Mkt Cap
$204.2M
Volume
174,167.00
52W High
$11.04
52W Low
$4.61
PE Ratio
27.15
INFU Fundamentals
Price
$9.19
Prev Close
$8.56
Open
$8.63
50D MA
$8.48
Beta
1.15
Avg. Volume
135,338.30
EPS (Annual)
$0.3141
P/B
3.02
Rev/Employee
$279,058.37
$209.11
Loading...
Loading...

Earnings Recap

InfuSystem expects 2026 annual revenue to decrease by $7.1M due to contract restructuring, but anticipates 6% to 8% growth for the unaffected business, with Adjusted EBITDA margin maintained in the mid to low 20% range.

Bullish

InfuSystem achieved solid growth with full-year Adjusted EBITDA up 24% and strengthened its balance sheet, while strategic initiatives and diversified revenue streams, particularly in Wound Care, drove margin expansion.

Bearish

InfuSystem faces a $7.1M revenue reduction in 2026 due to contract restructuring, alongside increased selling, marketing, and G&A expenses. Patient Services gross margin also compressed from an unfavorable product mix.

Latest INFU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.